Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes MellitusA Matching-Adjusted Indirect Comparison of Randomized Trials

被引：0
|
作者：
James E. Signorovitch
Eric Q. Wu
Elyse Swallow
Evan Kantor
Liangyi Fan
Jean-Bernard Gruenberger
机构：
[1] Analysis Group,
[2] Inc.,undefined
[3] Novartis Pharma AG,undefined
来源：
Clinical Drug Investigation | 2011年 / 31卷
关键词：
Fasting Plasma Glucose; Glycaemic Control; Sitagliptin; Vildagliptin; Individual Patient Data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background and Objective: Vildagliptin and sitagliptin are oral dipeptidyl peptidase 4 inhibitors approved in Japan for the treatment of type 2 diabetes mellitus when adequate glycaemic control is not achieved with diet, exercise or sulphonylureas. The aim of this study was to compare 12-week glycaemic control with vildagliptin 50 mg twice daily versus sitagliptin 50 or 100 mg once daily in Japanese patients with type 2 diabetes.
引用
收藏
页码：665 / 674
页数：9
相关论文
共 50 条
  • [1] Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus
    Koyanagawa, Naohide
    Miyoshi, Hideaki
    Ono, Kota
    Nakamura, Akinobu
    Cho, Kyu Yong
    Yamamoto, Kohei
    Takano, Yoshinari
    Dan-noura, Midori
    Atsumi, Tatsuya
    ENDOCRINE JOURNAL, 2016, 63 (08) : 747 - 753
  • [2] Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial
    Kothny, Wolfgang
    Lukashevich, Valentina
    Foley, James E.
    Rendell, Marc S.
    Schweizer, Anja
    DIABETOLOGIA, 2015, 58 (09) : 2020 - 2026
  • [3] The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
    Cai, L.
    Cai, Y.
    Lu, Z. J.
    Zhang, Y.
    Liu, P.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) : 386 - 398
  • [4] Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial
    Wolfgang Kothny
    Valentina Lukashevich
    James E. Foley
    Marc S. Rendell
    Anja Schweizer
    Diabetologia, 2015, 58 : 2020 - 2026
  • [5] Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes switched from glinides
    Tanaka, Tsuyoshi
    Goto, Hiroyuki
    Araki, Rika
    Yamamoto, Mika
    Tanaka, Takashi
    Fujiwara, Ryoko
    Murata, Kazuya
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (02) : 199 - 205
  • [6] Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
    Sato, Seiji
    Saisho, Yoshifumi
    Kou, Kinsei
    Meguro, Shu
    Tanaka, Masami
    Irie, Junichiro
    Kawai, Toshihide
    Itoh, Hiroshi
    PLOS ONE, 2015, 10 (03):
  • [7] Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial
    Iwamoto, Y.
    Tajima, N.
    Kadowaki, T.
    Nonaka, K.
    Taniguchi, T.
    Nishii, M.
    Ferreira, J. C. Arjona
    Amatruda, J. M.
    DIABETES OBESITY & METABOLISM, 2010, 12 (07): : 613 - 622
  • [8] Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
    Shimoda, Seiya
    Iwashita, Shinsuke
    Sekigami, Taiji
    Furukawa, Noboru
    Matsuo, Yasuto
    Ichimori, Shinji
    Goto, Rieko
    Maeda, Takako
    Watanabe, Eiichiro
    Kondo, Tatsuya
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Nishida, Kenro
    Araki, Eiichi
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) : 320 - 326
  • [9] The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes
    Kodera, Ryo
    Shikata, Kenichi
    Nakamura, Akihiko
    Okazaki, Satoru
    Nagase, Ryo
    Nakatou, Tatsuaki
    Haisa, Shigeru
    Hida, Kazuyuki
    Miyashita, Katsuhiro
    Makino, Hirofumi
    INTERNAL MEDICINE, 2017, 56 (06) : 605 - 613
  • [10] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
12345